Quinn William P. — SEC Form 4 filings
SEC reporting owner CIK 1724190. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-03-06 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 5,250 shares, $4,097 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 2,500 shares @ $0.64 ($1,594) in Bolt Biotherapeutics, Inc., filed 2025-05-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | President, CEO and CFO, Director | 6 | 4 legs · 5,250 sh · $4,097 | — | 21 |
Form 4 filings — Quinn William P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $4.61 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 7,614 (derivative) · Disposition to issuer (D): 7,614 (derivative) · Grant/award (A): 3,927 (derivative) · Disposition to issuer (D): 3,927 (derivative) · Grant/award (A): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +10 more | EDGAR |
| 2025-10-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $5.49 · Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-05-05 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 2,500 @ $0.50 · Purchase (P): 2,500 @ $0.64 · Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 440,000 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724190 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →